Lennon David James 4
4 · Aadi Bioscience, Inc. · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Lennon David James
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Restricted Stock Units
2023-10-02+32,558→ 32,558 total→ Common Stock (32,558 underlying) - Award
Stock Option (right to buy)
2023-10-02+490,000→ 490,000 totalExercise: $0.00Exp: 2033-10-02→ Common Stock (490,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
- [F2]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the RSUs subject to the award shall vest on October 2, 2024.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2023 Inducement Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest one (1) year after the Date of Grant, and one-forty-eighth (1/48th) of the shares subject to the option shall vest monthly thereafter on the same day of the month as the Date of Grant (and if there is no corresponding day, the last day of the month), such that the option will be fully vested and exercisable four (4) years from the Date of Grant. "Date of Grant" shall mean October 2, 2023.